佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: 21century

【IHH 5225 交流专区】综合保健控股

  [复制链接]
发表于 27-12-2018 06:00 AM | 显示全部楼层
Date of change
27 Nov 2018
Name
DATO' MOHAMMED AZLAN BIN HASHIM
Age
61
Gender
Male
Nationality
Malaysia
Type of change
Redesignation
Previous Position
Non Executive Chairman
New Position
Non Executive Chairman
Directorate
Independent and Non Executive
Qualifications
No
Qualifications
Major/Field of Study
Institute/University
Additional Information
1
Degree
Economics
Monash University
2
Professional Qualification
Fellow Member
Institute of Chartered Accountants, Australia
3
Professional Qualification
Member
Malaysian Institute of Accountants
4
Professional Qualification
Fellow Member
Malaysian Institute of Directors
5
Professional Qualification
Fellow Member
The Malaysian Institute of Chartered Secretaries and Administrators

Working experience and occupation
Prior to his appointment as Deputy Chairman on IHH Healthcare Berhad's ("IHH") Board of Directors in 2011, Dato' Mohammed Azlan bin Hashim ("Dato' Azlan") was the Executive Chairman of the (then) Kuala Lumpur Stock Exchange Group from 1998 to 2004. Dato' Azlan was re-designated as Chairman (Non-Independent Non-Executive) of IHH on 1 January 2018.Dato' Azlan began his career as an auditor at Peat Marwick, Mitchell & Co in Australia and thereafter served in various senior management roles at Amanah-Chase Merchant Bank Berhad, Sapura Holdings Sdn Bhd, Bumiputra Merchant Bankers Berhad, Kumpulan Fima Berhad and Amanah Capital Malaysia Berhad.

回复

使用道具 举报


ADVERTISEMENT

发表于 30-12-2018 07:04 AM | 显示全部楼层
IHH HEALTHCARE BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
Others
Details of corporate proposal
(i)        The exercise by Mehmet Ali Aydinlar ("MAA") and Hatice Seher Aydinlar ("HSA") of the option under the Shareholders Agreement dated 23 December 2011 entered between IHH Healthcare Berhad ("IHH"), Integrated Healthcare Hastaneler Turkey Sdn Bhd, Bagan Lalang Ventures Sdn Bhd ("Bagan Lalang"), MAA and HSA ("Shareholders Agreement") held by MAA and HSA to convert their class A shares in Acibadem Saglik Yatirimlari Holding A.S. ("Acibadem Holding") representing approximately 15% equity interest in Acibadem Holding into new ordinary shares in IHH ("IHH Shares"); and (ii)        The exercise by Bagan Lalang of the option under the Shareholders Agreement held by Bagan Lalang to convert its class B shares in Acibadem Holding representing approximately 15% equity interest in Acibadem Holding into new IHH Shares.
No. of shares issued under this corporate proposal
524,492,824
Issue price per share ($$)
Malaysian Ringgit (MYR)   5.5900
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
8,769,296,463
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 19,793,780,772.020
Listing Date
30 Nov 2018

回复

使用道具 举报

发表于 30-12-2018 08:15 AM | 显示全部楼层
本帖最后由 icy97 于 7-1-2019 01:17 AM 编辑

三井物产加码16%晋大股东-ihh医保盘中飙10%
http://www.enanyang.my/news/20181130/三井物产加码16晋大股东br-ihh医保盘中飙10/

Name
MITSUI & CO., LTD
Address
1-3, Marunouchi 1-Chome, Chiyoda-ku
Tokyo
100-8931
Japan.
Company No.
1010001008767
Nationality/Country of incorporation
Japan
Descriptions (Class)
Ordinary shares
Details of changes
No
Date of change
No of securities
Type of TransactionNature of Interest
128 Nov 2018
1,403,087,400
AcquiredDirect Interest
Name of registered holder
Mitsui & Co., Ltd
Address of registered holder
1-3, Marunouchi 1-Chome, Chiyoda-Ku, Tokyo 100-8631, Japan
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred
Mitsui & Co., Ltd ("Mitsui") has entered into a Share Purchase Agreement dated 28 November 2018 with Pulau Memutik Ventures Sdn. Bhd. ("PMVSB") , pursuant to which Mitsui has agreed, subject to completion of the issuance of 524,492,824 new shares in IHH Healthcare Berhad ("IHH") pursuant to an exercise of an option to convert the equity interest in Acibadem Saglik Yatirimlari Holding A.S. held by various persons ("Issuance") and the fulfillment of conditions precedent, to acquire shares in IHH from PMVSB, representing 16% of the enlarged share capital of IHH after the completion of the Issuance.
Nature of interest
Direct Interest
Direct (units)
1,485,400,000
Direct (%)
18.028
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Total no of securities after change
1,485,400,000
Date of notice
28 Nov 2018
Date notice received by Listed Issuer
29 Nov 2018

回复

使用道具 举报

发表于 2-1-2019 06:47 AM | 显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)
IHH HEALTHCARE BERHAD
Particulars of Substantial Securities Holder
Name
MR MEHMET ALI AYDINLAR
Nationality/Country of incorporation
Turkey
Descriptions (Class)
Ordinary shares
Name & address of registered holder
Citibank N.A. Singapore Private Limited5 Changi Business Park,Crescent #05,Singapore 486027
Date interest acquired & no of securities acquired
Date interest acquired
29 Nov 2018
No of securities
262,246,412
Circumstances by reason of which Securities Holder has interest
Exercise of Options granted pursuant to the terms of the Shareholders' Agreement dated 23 December 2011 entered into by IHH Healthcare Berhad, Integrated Healthcare Hastaneler Turkey Sdn Bhd, Bagan Lalang Ventures Sdn Bhd, Mehmet Ali Aydinlar and Hatice Seher Aydinlar
Nature of interest
Direct and Indirect Interest
Total no of securities after change
Direct (units)
420,244,132
Direct (%)
4.792
Indirect/deemed interest (units)
107,767,141
Indirect/deemed interest (%)
1.229
Date of notice
30 Nov 2018
Date notice received by Listed Issuer
30 Nov 2018

回复

使用道具 举报

发表于 2-1-2019 06:48 AM | 显示全部楼层

ype
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
RELATED PARTY TRANSACTIONS
Description
Acquisition by IHH, through its wholly-owned subsidiary, Integrated Healthcare Hastaneler Turkey Sdn Bhd, of approximately 30% additional equity interest in Acibadem Saglik Yatirimlari Holding A.S.
Reference is made to IHH’s announcement on 8 October 2018 (“Announcement”). Unless otherwise defined, the definitions set out in the Announcement shall apply herein.

The Board of IHH is pleased to announce that the Acquisition has been completed on 30 November 2018.

回复

使用道具 举报

发表于 2-1-2019 07:43 AM | 显示全部楼层
Name
PULAU MEMUTIK VENTURES SDN BHD
Address
Level 33, Tower 2, Petronas Twin Towers
Kuala Lumpur City Centre
Kuala Lumpur
50088 Wilayah Persekutuan
Malaysia.
Company No.
887202-X
Nationality/Country of incorporation
Malaysia
Descriptions (Class)
Ordinary shares
Details of changes
No
Date of change
No of securities
Type of TransactionNature of Interest
129 Nov 2018
262,246,412
OthersDirect Interest
Name of registered holder
PULAU MEMUTIK VENTURES SDN BHD
Address of registered holder
Level 33, Tower 2, Petronas Twin Towers, Kuala Lumpur City Centre, 50088 Kuala Lumpur
Description of "Others" Type of Transaction
Exercise of Option

Circumstances by reason of which change has occurred
Exercise of the Options granted under the Shareholders' Agreement dated 23 December 2011 entered into between IHH Healthcare Berhad ("IHH"), Integrated Healthcare Hastaneler Turkey Sdn Bhd, Bagan Lalang Ventures Sdn Bhd ("Bagan Lalang"), Mehmet Ali Aydinlar and Hatice Seher Aydinlar. Bagan Lalang has nominated Pulau Memutik Ventures Sdn Bhd, which is a wholly-owned subsidiary of Khazanah Nasional Berhad to receive the new IHH Shares.
Nature of interest
Direct Interest
Direct (units)
3,687,623,756
Direct (%)
42.052
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Total no of securities after change
3,687,623,756
Date of notice
30 Nov 2018
Date notice received by Listed Issuer
30 Nov 2018

回复

使用道具 举报

Follow Us
发表于 6-1-2019 07:30 AM | 显示全部楼层
回复

使用道具 举报

发表于 8-1-2019 04:37 AM | 显示全部楼层
IHH明年分拆印度SRL醫療上市
財經 最後更新 2018年11月26日 19时58分
http://www.orientaldaily.com.my/s/269097

(吉隆坡26日訊)IHH醫療保健集團(IHH,5225,主板保健股)計劃在2019年安排旗下的SRL醫療公司上市,並在中長期內帶領這個品牌衝出海外。SRL醫療公司目前是富通醫療子公司,持股56.6%。而IHH醫療保健剛完成收購富通。

據消息人士指出,IHH醫療保健集團將為富通醫療提供額外200億盧比(約578萬令吉)的資金。

該公司早前已為這家印度醫療集團提供400億盧比的資金,這是收購富通醫療股權的條件之一。

該公司額外注入的資金,除了用作法定公開獻購、營運資金和其他方面的需求之外,還有向私募基金收購SRL醫療的31%股權。

消息人士稱,IHH醫療保健集團將SRL醫療公司分拆上市,需要6個月到1年的時間。

至於持有SRL醫療公司股權的私募基金,也正考慮脫售股權,預期很快就能簽署協議。

IHH醫療保健集團估計以110億至120億盧比收購上述股權。不僅如此,IHH醫療保健集團希望在年杪前,完成對富通股東展開的公開獻購。之後便會專注于發展醫療和間診業務。

該名消息人士也說,IHH醫療保健公司還計劃將SRL品牌推廣至國外市場,尤其是在該公司已有立足點的東南亞市場。

儘管如此,IHH並未回應此消息。
回复

使用道具 举报


ADVERTISEMENT

发表于 14-1-2019 11:44 PM | 显示全部楼层
本帖最后由 icy97 于 20-1-2019 07:22 AM 编辑

印度高庭下令暂停交易-ihh收购富通医疗恐流产
http://www.enanyang.my/news/20181214/印度高庭下令暂停交易-ihh收购富通医疗恐流产/


收购富通医院再受阻-ihh医疗寻求法律意见
http://www.chinapress.com.my/20181217/收购富通医院再受阻-ihh医疗寻求法律意见/

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
IHH HEALTHCARE BERHAD ("IHH" OR "THE COMPANY")(I) PROPOSED SUBSCRIPTION;(II) FORTIS OPEN OFFER; AND (III) MALAR OPEN OFFER.

回复

使用道具 举报

发表于 18-1-2019 04:21 AM | 显示全部楼层
回复

使用道具 举报

发表于 2-2-2019 06:27 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Completion of acquisition of RHT Health Trust's assets by Fortis Healthcare Limited

回复

使用道具 举报

发表于 4-3-2019 02:08 AM | 显示全部楼层
Loading FB Video...

回复

使用道具 举报

发表于 4-3-2019 07:05 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2018
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2018
31 Dec 2017
31 Dec 2018
31 Dec 2017
$$'000
$$'000
$$'000
$$'000
1Revenue
3,165,348
2,885,133
11,520,932
11,142,639
2Profit/(loss) before tax
812,878
102,397
752,470
1,164,453
3Profit/(loss) for the period
710,687
37,346
489,860
829,828
4Profit/(loss) attributable to ordinary equity holders of the parent
509,417
101,255
627,687
969,953
5Basic earnings/(loss) per share (Subunit)
5.78
0.95
6.54
11.31
6Proposed/Declared dividend per share (Subunit)
3.00
3.00
3.00
3.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.5100
2.6600

回复

使用道具 举报

发表于 5-3-2019 07:08 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
First and Final Single Tier Cash Dividend for financial year ended 31 December 2018
Pursuant to Paragraph 9.19(2) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors ("Board") of IHH Healthcare Berhad ("IHH") is pleased to propose a first and final single tier cash dividend of 3 sen per ordinary share of IHH (“Final Dividend”) for the financial year ended 31 December 2018, subject to the shareholders' approval at the forthcoming Ninth Annual General Meeting.  

The book closure and payment date in respect of the proposed Final Dividend will be determined by the Board at a later date.




回复

使用道具 举报

发表于 5-3-2019 07:08 AM | 显示全部楼层
回复

使用道具 举报

发表于 5-3-2019 07:30 AM | 显示全部楼层
Date of change
01 Mar 2019
Name
MR MEHMET ALI AYDINLAR
Age
62
Gender
Male
Nationality
Turkey
Type of change
Redesignation
Previous Position
Executive Director
New Position
Non Executive Director
Directorate
Non Independent and Non Executive
Qualifications
No
Qualifications
Major/Field of Study
Institute/University
Additional Information
1
Degree
Business Administration
Galatasaray Economyand Management College

Working experience and occupation
Mr. Aydinlar is presently the Chairman and Chief Executive Officer of Acibadem Saglik Yatirimlari Holding A.S. ("ASYH"), a 90%-owned subsidiary of IHH. He also serves as the Chairman of the Board of the ASYH group of companies which includes A Plus, Acibadem Project Management, Acibadem Mobile Services and Acibadem Labmed. He is also the Chairman of the Turkish Accredited Hospitals Association. As of 2015, Mr. Aydinlar has been serving on the board of the Foreign Economic Relations Board. This institution is responsible for leading foreign economic relations within the Turkish private sector in a myriad of sectors, as well as for increasing export volume of Turkish businesses and coordinating similar business development activities.A certified public accountant-turned-entrepreneur, Mr. Aydinlar has been recognised for his extensive experience in management and involvement in the healthcare sector since 1993. Being a philanthropist, Mr. Aydinlar is also the Chairman of the Board of Trustees of Acibadem University, an ambitious social responsibility undertaking he initiated to advance healthcare in Turkey through education and research.
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Interest in the securities of IHH as at 27 February 2019: Direct Interest1) 420,244,132 ordinary shares 2) 665,000 Long Term Incentive Plan (LTIP) units3) 2,283,000 Enterprise Option Scheme (EOS) options Indirect Interest107,319,041 ordinary shares



Remarks :
Mr. Aydnlar will be re-designated from Chairman and Chief Executive Officer ("CEO") of ASYH to Chairman of ASYH following his cessation as CEO of ASYH with effect from 1 March 2019. With his cessation as the CEO of ASYH, the Board resolved to re-designate Mr. Aydinlar as a Non-Executive Director of IHH with effect from 1 March 2019.


回复

使用道具 举报


ADVERTISEMENT

发表于 6-4-2019 07:07 AM | 显示全部楼层
Name
PULAU MEMUTIK VENTURES SDN BHD
Address
Level 33, Tower 2, Petronas Twin Towers
Kuala Lumpur City Centre
Kuala Lumpur
50088 Wilayah Persekutuan
Malaysia.
Company No.
887202-X
Nationality/Country of incorporation
Malaysia
Descriptions (Class)
Ordinary shares
Details of changes
No
Date of change
No of securities
Type of TransactionNature of Interest
119 Mar 2019
1,403,087,400
DisposedDirect Interest
Name of registered holder
Pulau Memutik Ventures Sdn Bhd
Address of registered holder
Level 33, Tower 2, Petronas Twin Towers, Kuala Lumpur City Centre, 50088 Kuala Lumpur
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred
Completion of Share Purchase Agreement dated 28 November 2018 between Pulau Memutik Ventures Sdn Bhd and Mitsui & Co., Ltd. on divestment of 1,403,087,400 shares in IHH Healthcare Berhad.
Nature of interest
Direct Interest
Direct (units)
2,284,536,356
Direct (%)
26.052
Indirect/deemed interest (units)
0
Indirect/deemed interest (%)
0
Total no of securities after change
2,284,536,356
Date of notice
22 Mar 2019
Date notice received by Listed Issuer
22 Mar 2019

回复

使用道具 举报

发表于 6-4-2019 07:07 AM | 显示全部楼层
Name
MITSUI & CO., LTD.
Address
1-3, Marunouchi 1-Chome
Chiyoda-ku
Tokyo
100-8631
Japan.
Company No.
1010001008767
Nationality/Country of incorporation
Japan
Descriptions (Class)
Ordinary shares
Details of changes
No
Date of change
No of securities
Type of TransactionNature of Interest
119 Mar 2019
1,403,087,400
AcquiredDirect Interest
Name of registered holder
Mitsui & Co., Ltd.
Address of registered holder
1-3, Marunouchi 1-Chome, Chiyoda-ku, Tokyo 100-8631, Japan
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred
Acquisition of shares pursuant to the Share Purchase Agreement dated 28 November 2018 with Pulau Memutik Ventures Sdn Bhd ("PMV"), pursuant to which Mitsui & Co., Ltd. has agreed, subject to the fulfillment of conditions precedent, to acquire shares in IHH Healthcare Berhad ("IHH"), representing 16% of the share capital of IHH from PMV.
Nature of interest
Direct Interest
Direct (units)
2,888,487,400
Direct (%)
32.939
Indirect/deemed interest (units)
0
Indirect/deemed interest (%)
0
Total no of securities after change
2,888,487,400
Date of notice
22 Mar 2019
Date notice received by Listed Issuer
22 Mar 2019

回复

使用道具 举报

发表于 10-4-2019 05:33 AM | 显示全部楼层
IHH HEALTHCARE BERHAD

EX-date
26 Jun 2019
Entitlement date
28 Jun 2019
Entitlement time
05:00 PM
Entitlement subject
First and Final Dividend
Entitlement description
A first and final single tier cash dividend of 3 sen per ordinary share for the financial year ended 31 December 2018
Period of interest payment
to
Financial Year End
31 Dec 2018
Share transfer book & register of members will be
to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no
BOARDROOM SHARE REGISTRARS SDN BHDLevel 6, Symphony HousePusat Dagangan Dana 1Jalan PJU 1A/4647301 Petaling JayaSelangor Darul EhsanTel:03-7849 0777Fax:03-7841 8151 / 8152
Payment date
18 Jul 2019
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers
28 Jun 2019
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit

c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)

Entitlement indicator
Currency
Currency
Malaysian Ringgit (MYR)
Entitlement in Currency
0.03

回复

使用道具 举报

发表于 11-4-2019 06:43 AM | 显示全部楼层
Type
Announcement
Subject
AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN
QUALIFIED OPINION
Description
Qualified Opinion on the Audited Financial Statements for the financial year ended 31 December 2018

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 17-6-2024 01:58 PM , Processed in 0.059882 second(s), 22 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表